Research Article

Evaluation of Retinal Structure and Optic Nerve Function Changes in Multiple Sclerosis: Longitudinal Study with 1-Year Follow-Up

Table 2

Comparison of BCVA, contrast sensitivity, GCIPL, RNFL, P100 latency, and fundus image between MS and healthy controls (HCs).

VariablenMSnHC value

Median (range)
BCVA (logmar)580.00 (0.00–1.77)440.00 (0.00–0.10)0.001b
Contrast sensitivity531.65 (0.90–1.95)441.95 (1.65–1.95)0.00000000028b

Mean ± standard deviation
GCIPL
 Mean5470.89 ± 10.604384.72 ± 2.990.00000000000036a
 Superior5471.11 ± 11.444386.05 ± 2.960.000000000083b
 Superonasal5471.00 ± 12.514387.58 ± 3.560.000000000033b
 Inferonasal5470.28 ± 12.744385.53 ± 3.990.0000000027b
 Inferior5469.35 ± 11.064382.30 ± 4.070.000000000022a
 Inferotemporal5471.83 ± 10.124383.72 ± 3.740.0000000021b
 Superotemporal5471.15 ± 9.824383.53 ± 4.000.00000000006b

RNFL
 Mean5488.48 ± 14.0844102.50 ± 7.760.000000016a
 Superior54115.69 ± 21.9544132.36 ± 12.340.000008a
 Nasal5468.17 ± 10.604471.73 ± 11.580.12a
 Inferior54110.28 ± 20.7844134.93 ± 15.140.00000000099a
 Temporal5459.37 ± 16.824470.80 ± 7.900.00003a
P100 latency54116.63 ± 19.19220100.62 ± 5.730.0000000098b

Fundus image; N (%)
 Normal31 (57.4)44 (100)0.00000075c
 Optic atrophy23 (42.6)0 (0,0)

BCVA: best-corrected visual acuity; GCIPL: ganglion cell inner plexiform layer; RNFL: retinal nerve fiber layer. aT-independent test, bMann–Whitney test, cChi-square test.